Wednesday, 10 September 2025

Strategy: Sep 2025

 


Despite tariff woes and the ICE raid on the US Hyundai plant, Kospi has hit a record high. I have decent exposure to Kospi via my large holding on Vanguard's Asia Pacific ETF VDPX. 


As everything seems to be hitting new highs, I have to be really disciplined about steady DCA of ETFs.  At the same time, I can't help but look at SREITs again and wonder if they are undervalued. I have bought tiny amounts of FLCT and CDLHT to top up my holdings.

Finally, I had some excess cash in my SRS, and while I primarily buy Lion Global All Seasons unit trusts with SRS cash, the 0.53% expense ratio of the JPMorgan Global Research Enhanced Index Equity SGD caught my eye. While obviously more expensive than an ETF, I think its potentially useful addition to my SRS portfolio. It basically tracks MSCI World and the using Magnificent 7 are all represented in the portfolio. In other words, this isn't a dividend fund so the fact that its subject to 30% withholding tax on US dividends isn't too big a problem. 





No comments:

Post a Comment